Nevertheless, p53 mutation status per se may not predict Dies1 expression, given that breast cancer cells MDA-MB-468 and MDA-MB-231, display high levels of Dies1 and mutations in p53 (homozygous R273H and heterozygous R280K33, respectively). This evidence concerns the gene TP53 and breast carcinoma.